Activist & passive stakes

Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.

Showing the last 10 days.Sign up free for 90 days
Amendments only.1–13 of 13
  • PassiveAmendment 2
    Nov 16, 2026
    NGNE · Neurogene Inc.
    Srinivas Akkaraju
    9.7% · 1,954,197 shSEC
  • PassiveAmendment 2
    Nov 16, 2026
    PMN · Promis Neurosciences Inc.
    Great Point Partners, LLC
    6.77% · 650,731 shSEC
  • PassiveAmendment 2
    Nov 16, 2026
    NMRA · Neumora Therapeutics, Inc.
    Paul L Berns
    5.4% · 10,201,627 shSEC
  • PassiveAmendment 2Below 5%
    Nov 16, 2026
    NGNE · Neurogene Inc.
    Julian C. Baker
    4.99% · 1,034,635 shSEC
  • PassiveAmendment 18Below 5%
    Nov 16, 2026
    NEU · Newmarket Corp
    The London Company
    3.94% · 246,331 shSEC
  • PassiveAmendment 2
    Nov 16, 2026
    NGNE · Neurogene Inc.
    RTW Investments, LP
    9.3% · 1,897,463 shSEC
  • PassiveAmendment 1Below 5%
    Nov 16, 2026
    NGNE · Neurogene Inc.
    Balyasny Asset Management L.P.
    1.52% · 303,994 shSEC
  • PassiveAmendment 3
    Nov 16, 2026
    NERV · Minerva Neurosciences, Inc.
    Balyasny Asset Management L.P.
    9.99% · 4,769,981 shSEC
  • PassiveAmendment 2
    Nov 16, 2026
    CTNM · Contineum Therapeutics, Inc.
    Balyasny Asset Management L.P.
    7.35% · 2,420,948 shSEC
  • PassiveAmendment 1
    Nov 14, 2026
    NERV · Minerva Neurosciences, Inc.
    Coastlands Capital LP
    9.99% · 5,052,055 shSEC
  • PassiveAmendment 6
    Nov 13, 2026
    CRTO · Criteo S.A.
    Neuberger Berman Group LLC
    15.4% · 7,540,326 shSEC
  • PassiveAmendment 1
    Nov 11, 2026
    Neuberger Asset-Based Credit Fund
    Neuberger Berman Group LLC
    80.7% · 9,779,272 shSEC
  • PassiveAmendment 5
    Nov 10, 2026
    NRXS · Neuraxis, INC
    Bigger Michael
    5.77% · 818,528 shSEC